(-0.17%) 5 203.75 points
(-0.13%) 39 143 points
(-0.24%) 18 144 points
(0.47%) $79.36
(0.37%) $2.20
(-0.01%) $2 322.00
(1.03%) $27.89
(0.70%) $991.50
(0.12%) $0.931
(0.21%) $10.91
(0.12%) $0.801
(0.30%) $92.02
4 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 3.44%
-2.57% INR 1 719.05
Live Chart Being Loaded With Signals
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates...
Stats | |
---|---|
Today's Volume | 46 134.00 |
Average Volume | 350 742 |
Market Cap | 88.06B |
EPS | INR0 ( 2024-02-04 ) |
Next earnings date | ( INR13.40 ) 2024-05-13 |
Last Dividend | INR8.00 ( 2023-02-23 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 70.54 |
ATR14 | INR1.631 (0.09%) |
Volume Correlation
Metropolis Healthcare Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Metropolis Healthcare Correlation - Currency/Commodity
Metropolis Healthcare Financials
Annual | 2022 |
Revenue: | INR11.48B |
Gross Profit: | INR8.88B (77.37 %) |
EPS: | INR27.91 |
FY | 2022 |
Revenue: | INR11.48B |
Gross Profit: | INR8.88B (77.37 %) |
EPS: | INR27.91 |
FY | 2022 |
Revenue: | INR12.28B |
Gross Profit: | INR9.41B (76.59 %) |
EPS: | INR41.87 |
FY | 2021 |
Revenue: | INR9.98B |
Gross Profit: | INR7.38B (73.92 %) |
EPS: | INR35.97 |
Financial Reports:
No articles found.
Metropolis Healthcare Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR8.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR8.00 | 2020-02-13 |
Last Dividend | INR8.00 | 2023-02-23 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | INR32.00 | -- |
Avg. Dividend % Per Year | 0.30% | -- |
Score | 1.82 | -- |
Div. Sustainability Score | 3.98 | |
Div.Growth Potential Score | 3.78 | |
Div. Directional Score | 3.88 | -- |
Year | Amount | Yield |
---|---|---|
2020 | INR8.00 | 0.56% |
2021 | INR8.00 | 0.40% |
2022 | INR8.00 | 0.23% |
2023 | INR8.00 | 0.61% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SWARAJENG.NS | Dividend Knight | 2023-07-06 | Annually | 23 | 2.81% | |
NDRAUTO.NS | Dividend Junior | 2023-07-12 | Annually | 4 | 0.59% | |
ICICIGI.NS | Dividend Junior | 2023-06-12 | Annually | 8 | 0.36% | |
CENTENKA.NS | Dividend Junior | 2023-08-11 | Annually | 22 | 1.85% | |
RUPA.NS | Dividend Junior | 2023-08-01 | Annually | 13 | 0.60% | |
LINCOLN.NS | Dividend Junior | 2023-09-15 | Annually | 9 | 0.32% | |
GEECEE.NS | Dividend Junior | 2023-09-08 | Sporadic | 18 | 0.97% | |
ARIHANTCAP.NS | Dividend Junior | 2023-07-28 | Annually | 4 | 0.39% | |
TFCILTD.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 1.38% | |
ORICONENT.NS | Dividend Junior | 2023-09-13 | Annually | 10 | 1.41% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.108 | 1.500 | 7.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.122 | 1.500 | 9.75 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 8.18 | 1.000 | 8.08 | 8.08 | [3 - 30] |
operatingCashFlowPerShareTTM | 35.72 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 35.72 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.791 | 1.000 | 0.155 | 0.155 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.163 | 1.000 | 8.74 | 8.74 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.98 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 73.21 | 1.000 | 2.71 | 0 | [1 - 100] |
returnOnEquityTTM | 0.122 | 2.50 | 9.84 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 35.72 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.224 | 1.500 | 4.39 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 35.72 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -2.20 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.158 | 1.000 | 8.55 | 0 | [0.1 - 0.5] |
Total Score | 3.78 |
Metropolis Healthcare
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators